Identifying the primary site using gene expression profiling in patients with carcinoma of an unknown primary (CUP): A feasibility study from the GEFCAPI

Onkologie

Volumn 35, Issue 1-2, 2012, Pages 54-55

  Gross Goupil, Marine ^a   Massard, Christophe ^a   Lesimple, Thierry ^b   Merrouche, Yacine ^c   Blot, Emmanule ^d   Loriot, Yohan ^a   Mathieu, Marie C ^c   Fizazi, Karim ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b CENTRE EUGÈNE MARQUIS   (France)

^c Institut de Cancerologie de la Loire   (France)

^d CENTRE HENRI BECQUEREL   (France)

Author keywords

Cancer of unknown primary; Diagnosis; Gene expression

Indexed keywords

CARBOPLATIN; CETUXIMAB; CISPLATIN; FLUOROURACIL; GEMCITABINE; PACLITAXEL;

ADENOCARCINOMA; ADULT; AGED; AXILLARY LYMPH NODE; BILE DUCT CARCINOMA; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER LOCALIZATION; CANCER OF UNKNOWN PRIMARY SITE; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER REGRESSION; CLINICAL ARTICLE; COLON ADENOCARCINOMA; COLORECTAL CANCER; DNA MICROARRAY; FEASIBILITY STUDY; FEMALE; GENE EXPRESSION PROFILING; HEAD AND NECK CANCER; HUMAN; HUMAN TISSUE; HYPOPHARYNX CARCINOMA; KIDNEY CANCER; KIDNEY CELL CANCER; LETTER; LIVER CELL CARCINOMA; LUNG CANCER; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; LYMPH NODE DISSECTION; MELANOMA; MESOTHELIOMA; MICROARRAY ANALYSIS; MOUTH CARCINOMA; MULTIPLE CYCLE TREATMENT; OVARY CARCINOMA; PANCREAS CARCINOMA; PROGRESSION FREE SURVIVAL; RECTUM CARCINOMA; TRANSITIONAL CELL CARCINOMA; UNDIFFERENTIATED CARCINOMA;

ADULT; AGED; FEASIBILITY STUDIES; FEMALE; GENE EXPRESSION PROFILING; HUMANS; MALE; MIDDLE AGED; NEOPLASM PROTEINS; NEOPLASMS, UNKNOWN PRIMARY; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 84856938163     PISSN: 0378584X     EISSN: 14230240     Source Type: Journal    
DOI: 10.1159/000336300     Document Type: Letter

References (5)

1. ESMO minimal recommendations for diagnosis, treatment and follow-up of cancers of unknown primary site (CUP). Ann Oncol 2001;12:1057-1058.
2. Varadhachary GR, Talantov D, Raber MN, et al.: Molecular profiling of carcinoma of unknown primary and correlation with clinical evaluation. J Clin Oncol 2008;26:4442-4448.
3. Erlander MG, Moore MW, Cotter P, et al.: Molecular classification of carcinoma of unknown primary by gene expression profiling from formalin- fixed paraffin-embedded tissues. J Clin Oncol 2002;22(14S):9545.
4. Horlings HM, van Laar RK, Kerst JM, et al.: Gene expression profiling to identify the histogenetic origin of metastatic adenocarcinomas of unknown primary. J Clin Oncol 2008;26:4435-4441.
5. Bridgewater J, van Laar R, Floore A, Vant Veer L: Gene expression profiling may improve diagnosis in patients with carcinoma of unknown primary. Br J Cancer 2008;98:1425-1430. (Pubitemid 351543580)